Supplementary Tables 1 - 4 from Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML

Autor:	Peter Valent, Thomas Rülicke, Matthias Mayerhofer, Wolfgang R. Sperr, Werner Rabitsch, Berthold Streubel, Susanne Herndlhofer, Irina Sadovnik, Sabine Cerny-Reiterer, Michael Willmann, Gregor Hoermann, Harald Herrmann, Katharina Blatt
Rok vydání:	2023
DOI:	10.1158/1078-0432.22448301.v1
Popis:	PDF file - 85K, Supplementary Table S1: Characteristics of patients with MDS Supplementary Table S2: Characteristics of patients with AML Supplementary Table S3: Characteristics of patients with CML, CMML, MPS, AUL, and ALL Supplementary Table S4: Characteristics of patients with ICUS, normal/reactive bone marrow and long-term complete remission.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbc14d9bd431cb4b2cc6a98ae0c327a https://doi.org/10.1158/1078-0432.22448301.v1 Zobrazit plný text záznamu